2.67% Liabilities 309.33 283.75 25.58 9.01% Shareholders' equity 670.98 671.07 (0.09) (0.01%) Issued and fully paid-up common share (Million Share) 565.14 565.14 0.00 0.00% Par (Baht) 0.50 0.50 0.00 0.00
, targeting steel customers, coming on line in the next few months this part of the order book will pick up. Certain other key segments like chemical and construction also show positive tendencies. The strength
the revenue of the Company. Moreover, the balance of trade accounts receivable which was overdue by 6 - 12 months was THB 130.77 million, it has been collected in total of THB 39.65 million (up to 9
DISCUSSION AND ANALYSIS FOR PERIOD ENDED 31 MARCH 2018 3.3. Cash Flow Analysis Cash and cash equivalents in 1Q 2018 increased to 120mTHB, up by 70mTHB from the 50mTHB at the end of 2017 Net cashflow from
292.87 million and THB 263.02 million respectively. This is equivalent to a decrease of 11.35% compared to the same period last year. In addition, sales expenses to sales revenue ratio edged up a little
equity shares issued for payment of assets Equity shares issued for payment of assets x 100 Issued and paid-up shares of the Company This cannot be calculated. Upon combination of the transactions on
edged up a little from 35.04% to 37.80% as the Company incurred marketing expenses from new products launched in October. Table 7: Sales Expenses by Type of Expenses for the Three Months Period Ended 30
compared to 114 days as of 31 December 2018. AGEING OF TRADE RECEIVABLES (THB mn) 31 DECEMBER 2018 (Restated) 30 SEPTEMBER 2019 Not yet due 273 258 Up to 3 months 145 215 3 - 6 months 67 51 6 - 12 months 13
December 2019. 1 Calculated from the purchase price at Baht 19,434,749.25 plus interest at the rate of 6 percent per annum up to the full payment date of Baht 1,685,420.74. 7 7. The Opinion of the Board of
ช่ือผู้จัดการกองทุน ช่ือผู้จัดการกองทุน (back-up) กองทุนเปิด ทิสโก้ ไบโอเทคโนโลยี เฮลธ์แคร์ คุณธีระศักด์ิ บุญญาเสถียร คุณสากล รัตนวรี ข้อมูลรายงานการถือหน่วยลงทุนเกนิ 1 ใน 3 กองทุนเปิด ทิสโก้ ไบโอเทคโนโลยี